Axxam supports the discovery efforts of its partners by providing tools, solutions and services for the hit discovery process.
A team of highly skilled scientists with a proven performance-driven attitude provides access to its comprehensive discovery platforms, which includes expertise in:
- Molecular biology (cloning, gene expression analysis, protein expression, genomic engineering)
- Assay development (cellular and biochemical systems)
- Reagent provision (proteins and cell lines)
- Off-the-shelf assays ready for profiling and HTS
- Fully automated High Throughput Screening (various read-outs including radiometric formats)
- Fully automated High Content Screening
- Access to the AXXDIV3.0 compound collection (around 275,000 compounds)
- Compound management
- Hit follow-up programs
- Electrophysiology (manual and automated)
- Safety and liability profiling
- Innovative technologies for smarter assays
Our research teams work closely with client scientists to translate project objectives into research plans.
Collaborating with us will give you the advantage of combined discovery expertise and target knowledge, derived from our historical pharma industry background.
We understand your needs and provide solutions for even your most challenging projects.